TB500

CAS No. 885340-08-9

TB500( —— )

Catalog No. M30027 CAS No. 885340-08-9

TB-500 is a synthesised peptide, essentially a short-chain version of the naturally occurring Thymosin Beta-4.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 32 In Stock
5MG 52 In Stock
10MG 86 In Stock
25MG 155 In Stock
50MG 226 In Stock
100MG 334 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TB500
  • Note
    Research use only, not for human use.
  • Brief Description
    TB-500 is a synthesised peptide, essentially a short-chain version of the naturally occurring Thymosin Beta-4.
  • Description
    TB-500 is a synthesised peptide, essentially a short-chain version of the naturally occurring Thymosin Beta-4.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    885340-08-9
  • Formula Weight
    889.01
  • Molecular Formula
    C38H68N10O14
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 250 mg/mL (281.21 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Diaziquone

    Diaziquone (NSC-182986) is a water-soluble synthetic azacyclic benzoquinone that enhances penetration of the blood-brain barrier, has antitumor activity, and is used in the treatment of extreme renal failure.

  • Slingshot inhibitor ...

    Slingshot inhibitor D3 is a potent inhibitor of the Protein Phosphatase Slingshot.

  • Terlipressin

    Terlipressin is a vasopressin analogue with potent vasoactive properties. Terlipressin is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin exerts anti-inflammatory and anti-oxidative effects. Terlipressin has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.